the-infoshop.com - The vertical markets research portal
View CartView Cart
Global Information, Inc.
US: +1-860-674-8796
EU: +32-2-535-7543
SG: +65-6223-2436
  Home | Category | Publishers | Custom Research | E-mail Alert | About Us | Contact Us | Site Map |
 

* View All Categories
View Conferences
Japanese Korean Chinese

Market Research Report

Toxicity Biomarkers: Promising Tools for Accelerated Drug Development

Published by Decision Resources, Inc. Contact us : +1-860-674-8796
Published 2006/12 Content info 27 Pages
Product code DR45811
Price From  US $ 1112 Order/Price list
US $ 1112 PDF by E-mail (Single User License)
Delivery Time
PDF by E-Mail
Approx. 1-2 business days
Hard Copy/CD-ROM
Approx. 3-4 business days
If you need expedited delivery, please call us.
Description TOC

Table of Contents

  • Executive Summary
  • Strategic Considerations
  • Stakeholder Implications
  • Drug Toxicity: An Ongoing Challenge for Developers
  • Drawbacks of Traditional Approaches to Toxicology
  • Applications and Benefits of Biomarkers of Toxicity in Drug Development
  • What Is a Biomarker?
  • Why Use Biomarkers of Toxicity?
  • Toxicogenomics: Technologies for Identifying Biomarkers of Toxicity
  • Gene Expression Profiling
  • Proteomics
  • Metabolic Profiling
  • Genotyping
  • Examples of Potential Biomarkers of Toxicity
  • α-Glutathion S-Transferase in Hepatotoxicity
  • Kidney Injury Molecule-1 in Nephrotoxicity
  • Troponins in Cardiotoxicity
  • Inhibin B in Testicular Toxicity
  • Challenges in Integrating Biomarkers of Toxicity into Drug Development
  • Technical Issues
  • Biomarker Validation
  • Bioinformatics/Integration
  • Intellectual Property
  • The Critical Path Initiative and Biomarker Discovery
  • Industry Trends
  • Collaborative Agreements
  • Aureus Pharma, ChemAxon, Sanofi-Aventis, and Budapest University of Technology and Economics
  • BG Medicine 17
  • Ciphergen Biosystems
  • Clinical Data
  • Gene Logic
  • Iconix Biosciences
  • Metabometrix
  • RxGen
  • Consortia
  • International Life Science Institute Health and Environmental Science Institute
  • Predictive Safety Testing Consortium
  • Consortium for Metabonomic Toxicology
  • Drug-Induced Liver Injury Network
  • Outlook for Biomarkers of Toxicity

Tables

  • 1. Select Drug Withdrawals Due to Safety Issues, 1997-2005
  • 2. Metabolizing Enzymes Implicated in Drug-Induced Toxicity
  • 3. Biomarker Classification
  • 4. Profiled Companies Active in Development of Biomarkers of Toxicity
  • 5. Profile of the Affymetrix/Iconix ToxFX Chip

Figures

  • 1. Reasons for Termination of New Compounds
  • 2. Applications and Benefits of Biomarkers of Toxicity in Drug Development
  • 3. Schematic Example of Using DNA Microarray Technology in Biomarker Discovery
  • 4. 2DGE/MS-Based Protein Analysis Scheme in Biomarker Discovery
  • 5. Framework for Data Integration from Different Technology Platforms
Related Report
Back to Top
Please inform me when related publications are released
InfoWatch

US: 1-860-674-8796 EU: 32-2-535-7543 SG: 65-6223-2436
The vertical markets research portal
© 2009, the-infoshop.com by Global Information, Inc. All rights reserved.